BusinessGalectin Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Business UpdateBy Nasdaq OMXMar 21, 2017, 12:30 PM UTC
BusinessGalectin Therapeutics to Present at 29th Annual ROTH ConferenceBy Nasdaq OMXMar 9, 2017, 1:30 PM UTC
BusinessGalectin Therapeutics Announces Achievement of Key Milestones Related to NASH-CX Clinical TrialBy Nasdaq OMXFeb 1, 2017, 1:10 PM UTC
BusinessGalectin Therapeutics to Webcast Corporate Update At Annual Meeting of StockholdersBy Nasdaq OMXDec 8, 2016, 1:00 PM UTC
BusinessOcera to Present at the Cowen and Company 36th Annual Health Care ConferenceBy Nasdaq OMXFeb 29, 2016, 9:05 PM UTC